A glycoside analog of mammalian oligomannose formulated with a TLR4-stimulating adjuvant elicits HIV-1 cross-reactive antibodies

Further steps to understanding conditions for eliciting HIV-neutralizing antibodies with specificity for oligomannose published in @Scientific Reports [article] and highlighted in SFU’s Scholarly Impact of the Week [PDF]